基本信息
文件名称:AZD0516-生命科学试剂-MCE.pdf
文件大小:446.14 KB
总页数:1 页
更新时间:2025-05-22
总字数:约1.91千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

AZD0516

Cat.No.:HY-173639

作?靶点:Antibody-DrugConjugates(ADCs);Topoisomerase

作?通路:Antibody-drugConjugate/ADCRelated;CellCycle/DNA

Damage

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性AZD0516是?款靶向前列腺六跨膜上?抗原2(STEAP2)的?创抗体-药物偶联物(ADC)。由抗STEAP2单克隆

抗体(mAb)通过链间半胱氨酸与马来酰亚胺反应性、β-葡萄糖醛酸酶可裂解的连接?(HY-173635)和拓扑异

构酶1抑制剂Exatecan(HY-13631)偶联?成。AZD0516可?于前列腺癌的研究。

REFERENCES

[1].1158-PreclinicalcharacterizationofAZD0516,anovelSTEAP2antibody-drugconjugate(ADC)forthetreatmentofprostatecancer.

AACRAnnualMeeting2025ItineraryPlannerHome.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1MasterofBioactiveMolecules—您?边的抑制剂?师